HOME       CME/CE INFORMATION       PROGRAM DIRECTORS       NEWSLETTER ARCHIVE       EDIT PROFILE       RECOMMEND TO A COLLEAGUE

VOLUME 2 – ISSUE 4 Featured Cases: Allergic Bronchopulmonary Aspergillosis (ABPA) At the conclusion of this activity, participants will demonstrate the ability to: Evaluate the possibility of ABPA as a cause of cystic fibrosis pulmonary exacerbations and describe how to initiate treatment Discuss the circumstances meriting initiation of antifungal therapy Describe how to optimize the use of antifungals and explain how Aspergillosis respiratory infection without ABPA may lead to decline in lung function. This audio activity has been developed for clinicians caring for patients with issues related to cystic fibrosis. You can also read the companion newsletter. In this edition Dr. Moss will help expand our understanding of ABPA with the discussion some typical case scenarios. Unlabeled/Unapproved Uses The author has indicated that none of the agents discussed are approved for ABPA. Richard B. Moss, M.D. Professor of Pediatrics (Pulmonary Medicine and Allergy-Immunology) Co-Director, Cystic Fibrosis Center Lucile Packard Children’s Hospital Stanford Hospital and Clinics Stanford University Medical Center Center of Excellence in Pulmonary Biology Department of Pediatrics Stanford University Palo Alto, California       Guest Faculty Disclosure Richard Moss, MD has disclosed: Principal Investigator: Gilead, GlaxoSmithKline, Inspire Pharmaceuticals, PTC Therapeutics, Inc., Vertex Pharmaceuticals Consultant: Aridis Pharmaceuticals, Arriva Pharmaceuticals, Inc., Genentech, Inc., Inspire Pharmaceuticals, Johnson & Johnson, Lantibio, Inc./AOP Orphan Pharmaceuticals AG, MPEX Pharmaceuticals, Novartis Pharmaceuticals, PTC Therapeutics, Inc., Vertex Pharmaceuticals Stock Shareholder: Genentech, Inc., Gilead Speaker Bureau: Novartis Pharmaceuticals, Genentech, Inc. Release Date March 9, 2010 Expiration Date March 8, 2012 Next Issue April 13, 2010 Michael P. Boyle, MD, FCCP Associate Professor of Medicine Director, Adult Cystic Fibrosis Program The Johns Hopkins University Baltimore, MD Peter J. Mogayzel, Jr., MD, PhD Associate Professor of Pediatrics Director, Cystic Fibrosis Center The Johns Hopkins University Baltimore, MD Donna W. Peeler, RN, BSN Pediatric Clinical Coordinator Cystic Fibrosis Center The Johns Hopkins University Baltimore, MD Meghan Ramsay, MS, CRNP Pediatric Clinical Coordinator Adult Clinical Coordinator Cystic Fibrosis Center The Johns Hopkins University Baltimore, MD

accreditation statements This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing . The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians. The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. credit designations Physicians Podcast: The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Nurses Podcast: 0.50 contact hour Educational Activity is provided by The Institute for Johns Hopkins Nursing. Each podcast carries a maximum of 0.50 contact hours or a total of 3.0 contact hours for the six podcasts in this program. To obtain contact hours, you must complete this Education Activity and post-test before March 8, 2012. Allied Health Podcast: The Johns Hopkins University has approved this activity for 0.75 contact hours for non-physicians. Respiratory Therapists For United States: Visit this page to confirm that your state will accept the CE Credits gained through this program. For Canada: Visit this page to confirm that your province will accept the CE Credits gained through this program. There are no prerequisites to participate in the activity. intended audience This activity has been developed for Pulmonologists, Pediatric Pulmonologists, Gastroenterologists, Pediatricians, Infectious disease specialists, Respiratory therapists, Dieticians, Nutritionists, Nurses, and Physical therapists. launch date This program launched on March 9, 2010, and is published monthly; activities expire two years from the date of broadcast, ending in March 8, 2012. post test To take the post-test for eCysticFibrosis Review you will need to visit The Johns Hopkins University School of Medicine’s CME website and The Institute for Johns Hopkins Nursing. If you have already registered for other Hopkins CE programs at these sites, simply enter the requested information when prompted. Otherwise, complete the registration form to begin the testing process. A passing grade of 83% or higher on the post-test/evaluation is required to receive CE credit. statement of responsibility The Johns Hopkins University School of Medicine and The Institute for Johns Hopkins Nursing take responsibility for the content, quality and scientific integrity of this CME/CE activity. internet cme/ce policy The Office of Continuing Medical Education (CME) at The Johns Hopkins University School of Medicine and The Institute for Johns Hopkins Nursing are committed to protect the privacy of its members and customers. The Johns Hopkins University maintains its Internet site as an information resource and service for physicians, other health professionals and the public. Continuing Medical Education at The Johns Hopkins University School of Medicine and The Institute for Johns Hopkins Nursing will keep your personal and credit information confidential when you participate in a CE Internet-based program. Your information will never be given to anyone outside The Johns Hopkins University program. CE collects only the information necessary to provide you with the service you request. faculty disclosure As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of Johns Hopkins University School of Medicine to require the disclosure of the existence of any relevant financial interest or any other relationship a faculty member or a provider has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The presenting faculty reported the following: Michael P. Boyle, MD, FCCPD discloses that he has received grant/research support Vertex Pharmaceuticals, Inc. Peter J. Mogayzel, Jr, MD, PhD discloses that he has no financial relationship with commercial supporters. Meghan Ramsay, MS, CRNP discloses that she has no financial relationship with commercial supporters. Donna W. Peeler, RN discloses that she has no financial relationship with commercial supporters. Guest Author's Disclosures disclaimer statement The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of Johns Hopkins University name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients. hardware & software requirements Pentium 800 processor or greater, Windows 98/NT/2000/XP or Mac OS 9/X, Microsoft Internet Explorer 5.5 or later, 56K Modem or better, Windows Media Player 9.0 or later, 128 MB of RAM, monitor settings: high color at 800 x 600 pixels, sound card and speakers, Adobe Acrobat Reader.

If you want to now listen to the eCysticFibrosis Review podcast, just click on the button above. This will open your Internet browser to play the podcast by streaming the media via the web. Please note: This podcast file is large so please be patient while the content downloads. Save the podcast to your computer. Once saved you can manage and play the file like any song or music using your music software (iTunes, Windows Media, Real Player, etc.). You can also transfer the podcast file to your iPod, MP3 player and listen while on-the-go. Like any RSS subscription, when you subscribe to this Review you will automatically receive each new edition, downloaded to your hard drive as soon as it becomes available. You may manage and play the downloaded podcast file like any song or audio file by using your music software (iTunes, Windows Media, Real Player, etc.). You can also transfer the podcast file to your iPod, MP3 player to listen while on-the-go. COMPLETE THE POST-TEST Step 1. Click on the appropriate link below. This will take you to the post-test. Step 2. If you have participated in a Johns Hopkins on-line course, login. Otherwise, please register. Step 3. Complete the post-test and course evaluation. Step 4. Print out your certificate.   Respiratory Therapists Visit this page to confirm that your state will accept the CE Credits gained through this program or click on the link below to go directly to the post-test.   »Download the podcast transcript »Go to the companion newsletter »Learn more about podcasting   Help other clinicians find solutions to their biggest CF challenges. Forward a link to the eCysticFibrosis Review website to a colleague   Vitamin D and Bone Health

© 2010 JHUSOM, IJHN and eCysticFibrosis Review Presented by JHUSOM in collaboration with DKBmed.